Ginkgo Bioworks Holdings Inc
For the period ended Aug 14, 2024. Filed Aug 15, 2024.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Aug 14, 2024 · Filed Aug 15, 2024
Use the contents to explore the available documents and sections.
Contents
1. Reverse Stock Split Proposal
- Reverse Stock Split Proposal
Item 1 was to approve Article V, Section 1(c) of the Company’s Amended and Restated Certificate of Incorporation, to effect, at the discretion of the Company’s Board of Directors (the “Board”), a reverse stock split of the issued and outstanding shares of Class A common stock and Class B common stock, which would combine a whole number of outstanding shares of the Class A common stock and Class B common stock in a range of not less than one-for-twenty (1:20) shares and not more than one-for-forty (1:40) shares into one share of Class A common stock or Class B common stock, as applicable, and reduce the number of outstanding shares of Class A common stock and Class B common stock (the “Reverse Stock Split Proposal”), designated to be voted upon by the holders of Class A common stock and Class B common stock, voting together as a single class. The results of the vote were as follows:
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.